Anti-tumor Activity of N [(E)-1-(2-hydroxyphenyl) Methylidene], N-[(E)-2-Phenylethylidene], N [(E,2E)-3-Phenyl-2-propenylidene], and N [(E)ethylidene] Isonicotinohydrazide on K562 and Jurkat Cell Lines.
Using the water eliminated mechanism, reactions of 4-pyridinecarboxylic acid hydrazide and salicylaldehyde, benzaldehyde, cinnamaldehyde, and formaldehyde afforded the corresponding N(4)[(E)-1-(2-hydroxyphenyl) methylidene] (NHPM), N(4)-[(E)-2-phenylethylidene] (NPI), N(4)[(E,2E)-3-phenyl-2-propenylidene] (NPPI), and N(4)[(E) ethylidene] (NEI) isonicotinohydrazide, in high yields, after several minutes, as reported. These new compounds have shown antitumor activity against two kinds of cancer cells, which are K562 (human chronic myeloid leukemia) and Jurkat (human T lymphocyte carcinoma).
Department of Chemistry, Islamic Azad University, Young Researchers Club, Ardabil, Iran.
F
F
Shabani
S
S
Ghammamy
A
A
Jahazi
F
F
Siavoshifar
J Inorg Biochem. 1998 Jul;70(3-4):219-26
9720307
Eur J Med Chem. 2008 Apr;43(4):675-82
17673337
Bioorg Med Chem Lett. 1999 Dec 6;9(23):3319-24
10612592
J Mol Graph Model. 2007 Nov;26(4):740-7
17540591
Bioinorg Chem Appl. 2008;:501021
19190768
J Inorg Biochem. 2004 Jan;98(1):98-104
14659638